Separate names with a comma.
[ATTACH] You know what else hurts? I still think FX-322 wasn’t a complete failure, they just needed more time and research but unfortunately ran...
TL;DR: 2023 is do or die for Frequency Therapeutics. There is something here but the results haven't been as consistent as desired and there are a...
Scientists from King’s College London, the Karolinska Institute, and Erasmus University have recently discovered ten additional genes connected to...
Does anyone have insight on the state of Frequency Therapeutics right now? I have been seeing a lot of new articles out there but no new...
Summary of this morning's presentation: Encouraging results and they seem to have something here and be on the right path, but it is not a...
More information --> Additional information link https://www.clarahealth.com/studies/hearing-study Another thing Exclusion Criteria: Evidence...
Clinical Study Sites New York, New York New York, New York (Actually NJ) Albany, New York Amherst, New York Richmond, Virginia Norfolk, Virginia...
Exclusion Criteria: 1. Subject has previously been randomized in a FX-322 clinical trial. Conflicting information?
Anyone watch the presentation this morning? Can anyone give a summary? Anything new?
Noise-induced hearing loss Age-related hearing loss Antibiotic related hearing loss (ototoxicity?) Viral/bacterial related hearing loss Congenital...
I just want to throw this out there. I had probed into the Phase 2 clinical trials and the following came up: - "The trial was looking...
I'm having trouble interpreting this. Can you link the tweet?
I suppose the focus should be on compassionate use access?
[ATTACH]
What's the best way to do this?
